BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)

3 posts

Biotech NewsAurinia Pharmaceuticals (AUPH) Hits 52-Week High

  • BioTech Health X
  • September 4, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a biopharmaceutical company dedicated to advancing treatments for serious autoimmune conditions that have…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAnalysts Are Bullish: Could Aurinia (AUPH) Be the Next Billion-Dollar Biotech Winner?

  • BioTech Health X
  • July 31, 2025
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for the treatment of…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAurinia Pharmaceuticals (AUPH) Just Turned Profitable — Is This the Most Undervalued Biotech Stock of 2025?

  • BioTech Health X
  • June 26, 2025
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a late-stage biopharmaceutical company headquartered in Victoria, British Columbia, with U.S. commercial operations…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Niagen Bioscience (NAGE) Up 503% in 3 Years
  • Corvus Pharmaceuticals (CRVS) Net Loss Doubles to $8M in Q2 2025
  • Kestra Medical (KMTS) Surges on 52% Revenue Growth
  • GlucoTrack (GCTK) Posts $9.6M Cash Reserves
  • Adverum (ADVM) Could Soar 460% With $19.75 Target
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • September 13, 2025
    Niagen Bioscience (NAGE) Up 503% in 3 Years
    • September 13, 2025
    Corvus Pharmaceuticals (CRVS) Net Loss Doubles to $8M in Q2 2025
    • September 13, 2025
    Kestra Medical (KMTS) Surges on 52% Revenue Growth
    • September 12, 2025
    GlucoTrack (GCTK) Posts $9.6M Cash Reserves
    • September 7, 2025
    Adverum (ADVM) Could Soar 460% With $19.75 Target
Recent Posts
  • Spero Therapeutics (SPRO) Surges After 200% Stock Jump on Phase 3 Success
    • September 7, 2025
  • Tiziana (TLSA) Surges 143% in 2025
    • September 7, 2025
  • OKYO Pharma (OKYO) Surges on 75% Pain Reduction in Phase 2 Trial
    • September 7, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (379)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top